Back to Search
Start Over
Risk for Cervical Intraepithelial Neoplasia Grade 3 or Higher in Follow-Up of Women With a Negative Cervical Biopsy.
- Source :
-
Journal of lower genital tract disease [J Low Genit Tract Dis] 2018 Jul; Vol. 22 (3), pp. 201-206. - Publication Year :
- 2018
-
Abstract
- Objective: The Norwegian Cervical Cancer Screening Programme recommends follow-up of histologically confirmed normal/cervical intraepithelial neoplasia (CIN) 1 with combined cytology and human papillomavirus testing within 6 to 12 months. This study examines adherence to guidelines and subsequent risk for CIN 3+ within this subset of women.<br />Materials and Methods: Women aged 25 to 69 years attending the Norwegian Cervical Cancer Screening Programme in Norway's 2 northernmost counties were included. An exposed cohort with histologically confirmed normal/CIN 1 after an atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion or atypical squamous cells - cannot exclude high-grade squamous intraepithelial lesion/high-grade squamous intraepithelial lesion enrolment cytology (n = 374) was compared with a nonexposed cohort with a normal enrolment cytology attending primary screening (N = 25,948). Risk calculations were stratified by outcomes of the first follow-up cytology. The study end point was CIN 3+ or censored at 78 months of follow-up.<br />Results: In the exposed cohort, the 42-month cumulative incidence of CIN 3+ was 9.4% (95% CI = 4.1-14.7) for women with an abnormal first follow-up cytology and 1.6% (95% CI = 0.0-3.4) for women with a normal first follow-up cytology versus 0.21% (95% CI = 0.15-0.27) in the nonexposed cohort (p < .01). The CIN 3+ risk was higher in the exposed cohort when the first follow-up cytology was abnormal (hazard ratio = 20.4, 95% CI = 11.2-37.1) compared with normal (hazard ratio = 4.7, 95% CI = 1.9-11.6) with the nonexposed cohort as reference.<br />Conclusions: After a negative cervical biopsy, a normal first follow-up cytology provided a CIN 3+ risk considered acceptable to recommend return to routine screening in 3 years. Cytology and human papillomavirus co-testing in post-colposcopy follow-up of negative biopsies may improve risk stratification.
- Subjects :
- Adult
Aged
Biopsy
Female
Follow-Up Studies
Guideline Adherence
Humans
Incidence
Middle Aged
Norway
Retrospective Studies
Risk Assessment
Squamous Intraepithelial Lesions of the Cervix diagnosis
Uterine Cervical Neoplasms diagnosis
Papillomavirus Infections diagnosis
Squamous Intraepithelial Lesions of the Cervix epidemiology
Uterine Cervical Neoplasms epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 1526-0976
- Volume :
- 22
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of lower genital tract disease
- Publication Type :
- Academic Journal
- Accession number :
- 29543686
- Full Text :
- https://doi.org/10.1097/LGT.0000000000000394